Stay updated on pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.

Latest updates to the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe revision label on the page was updated from v3.6.3 to v3.6.4, representing a minor update to the study record.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page no longer displays the study's disease label 'Prostate cancer' and the related topics entry 'MedlinePlus Genetics'.SummaryDifference0.2%

- Check31 days agoChange DetectedThe page now lists Prostate cancer and MedlinePlus Genetics under related topics, surfacing disease context and genetics resources alongside the study details.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page now displays Revision: v3.6.3, and earlier references such as Prostate cancer, related topics, MedlinePlus Genetics, and Revision: v3.6.0 have been removed.SummaryDifference0.2%

- Check45 days agoChange DetectedThe study page gains explicit tagging for Prostate cancer and a related topic entry for MedlinePlus Genetics. This links the content to disease-specific and genetics resources.SummaryDifference0.2%

- Check52 days agoChange DetectedNew help and navigation sections were added to the study page (How to Read a Study Record, Common Questions, How to Join a Study). A recruitment status note No longer looking for participants was added, and the Intervention/Treatment heading was reformatted, with an updated revision tag to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.